- Home
- CODA vs VERU Comparison
CODA vs VERU Comparison
Compare CODA & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODA
- VERU
- Stock Information
- Founded
- CODA 1994
- VERU 1971
- Country
- CODA United States
- VERU United States
- Employees
- CODA N/A
- VERU N/A
- Industry
- CODA Industrial Machinery/Components
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- CODA Industrials
- VERU Health Care
- Exchange
- CODA Nasdaq
- VERU Nasdaq
- Market Cap
- CODA 88.8M
- VERU 85.5M
- IPO Year
- CODA N/A
- VERU 1990
- Fundamental
- Price
- CODA $8.08
- VERU $3.61
- Analyst Decision
- CODA Strong Buy
- VERU Strong Buy
- Analyst Count
- CODA 1
- VERU 3
- Target Price
- CODA $11.00
- VERU $33.33
- AVG Volume (30 Days)
- CODA 80.8K
- VERU 126.9K
- Earning Date
- CODA 09-15-2025
- VERU 08-12-2025
- Dividend Yield
- CODA N/A
- VERU N/A
- EPS Growth
- CODA 15.09
- VERU N/A
- EPS
- CODA 0.30
- VERU N/A
- Revenue
- CODA $24,347,217.00
- VERU $16,886,419.00
- Revenue This Year
- CODA $30.82
- VERU N/A
- Revenue Next Year
- CODA $20.84
- VERU N/A
- P/E Ratio
- CODA $26.33
- VERU N/A
- Revenue Growth
- CODA 29.34
- VERU 337.24
- 52 Week Low
- CODA $5.76
- VERU $2.64
- 52 Week High
- CODA $9.89
- VERU $14.20
- Technical
- Relative Strength Index (RSI)
- CODA 52.95
- VERU 52.35
- Support Level
- CODA $7.85
- VERU $3.24
- Resistance Level
- CODA $8.80
- VERU $3.94
- Average True Range (ATR)
- CODA 0.38
- VERU 0.19
- MACD
- CODA 0.01
- VERU -0.10
- Stochastic Oscillator
- CODA 39.50
- VERU 91.50
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.